CAMBRIDGE, Mass. (AP) _ Momenta Pharmaceuticals Inc. (MNTA) on Thursday reported a loss of $69.9 million in its second quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 91 cents.
The biotechnology company posted revenue of $13 million in the period.
Momenta shares have more than doubled since the beginning of the year. The stock has risen 73 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MNTA at https://www.zacks.com/ap/MNTA